Although in recent years there has been great advancement in studies of the role of IL-33/ST2 in epithelium and the potential effects of its imbalanced expression on tissue function, there are still many questions regarding the impact of this system on IBD pathologies. This evidence concerns the gene IL33 and inflammatory bowel disease.